Insider · CIK 0001346164
Curran Simpson
Files at RGNX (REGENXBIO Inc.). First filing Sep 12, 2025, latest Oct 10, 2025.
In brief
Curran Simpson files SEC Form 4 as CEO and director at RGNX (REGENXBIO Inc.). Since Sep 12, 2025, Curran Simpson has reported 0 open-market buys worth $0 and 3 open-market sells worth $417k, the latest filed on Oct 10, 2025.
A track record needs three past buys with six months of prices behind them; Curran Simpson has 0, so none is measured yet.
The newest scored trade: sold $263k of RGNX on Oct 9, 2025, filed Oct 10, 2025, scored 18 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RGNX: REGENXBIO Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | REGENXBIO Inc. | $263k 20,811 shares | -9% | - | |
| 13Weak | REGENXBIO Inc. | $76k 7,624 shares | -3% | - | |
| 13Weak | REGENXBIO Inc. | $77k 7,734 shares | -3% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 9, 2025 | RGNX REGENXBIO INC | 20,811 0.04% of outstanding | $254k | Oct 9, 2025 | $154k |
| Sep 10, 2025 | RGNX REGENXBIO INC | 15,358 0.03% of outstanding | $152k | Sep 10, 2025 | none |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | RGNX REGENXBIO Inc. | AGrant or award Common Stock | +951 | $7.00 | $6,653 | 343,418 | Jul 6, 2026 |
| Jun 30, 2026 | RGNX REGENXBIO Inc. | AGrant or award Common Stock | +1,453 | $10.18 | $15k | 344,871 | Jul 6, 2026 |
| Jul 1, 2026 | RGNX REGENXBIO Inc. | FTax withholding Common Stock | -6,818 | $13.09 | $89k | 338,053 | Jul 6, 2026 |
| Jan 6, 2026 | RGNX REGENXBIO Inc. | AGrant or award Common Stock | +144,864 | $0.00 | $0 | 342,467 | Jan 8, 2026 |
| Jan 6, 2026 | RGNX REGENXBIO Inc. | AGrant or award Stock Options (Right to buy)derivative | +233,651 | $0.00 | $0 | 233,651 | Jan 8, 2026 |
| Jan 2, 2026 | RGNX REGENXBIO Inc. | FTax withholding Common Stock | -18,559 | $14.40 | $267k | 197,603 | Jan 6, 2026 |
| Oct 9, 2025 | RGNX REGENXBIO Inc. | SOpen-market sale Common Stock10b5-1 | -20,811 | $12.62 | $263k | 216,162 | Oct 10, 2025 |
| Sep 29, 2025 | RGNX REGENXBIO Inc. | SOpen-market sale Common Stock10b5-1 | -7,624 | $10.03 | $76k | 236,973 | Oct 1, 2025 |
| Sep 10, 2025 | RGNX REGENXBIO Inc. | SOpen-market sale Common Stock10b5-1 | -7,734 | $10.02 | $77k | 244,597 | Sep 12, 2025 |
| Jul 1, 2025 | RGNX REGENXBIO Inc. | FTax withholding Common Stock | -4,701 | $8.23 | $39k | 252,331 | Jul 3, 2025 |
Questions about Curran Simpson
Answered from the filings on this page, as of the latest one.
Is Curran Simpson buying or selling?
Not in the last 12 months. Curran Simpson's latest open-market trade on SEC Form 4 was sold $263k of RGNX on Oct 9, 2025.
How did Curran Simpson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Curran Simpson has 0.
Where does Curran Simpson file Form 4?
Curran Simpson has filed Form 4 at RGNX (REGENXBIO Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.